Preferred Label : Orlistat;
MeSH definition : A lactone derivative of LEUCINE that acts as a pancreatic lipase inhibitor to limit
the absorption of dietary fat; it is used in the management of obesity.;
MeSH synonym : Tetrahydrolipstatin; THLP; Tetrahydrolipastatin;
MeSH hyponym : Ro 18 0647;
MeSH CAS label : L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))-;
MeSH Related Number : 96829-58-2 (Orlistat);
UNII : 95M8R751W8;
Origin ID : D000077403;
UMLS CUI : C0076275;
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
MeSH indexing information
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A lactone derivative of LEUCINE that acts as a pancreatic lipase inhibitor to limit
the absorption of dietary fat; it is used in the management of obesity.
http://www.cochrane.org/fr/CD007654/les-effets-long-terme-des-medicaments-amaigrissants-chez-les-personnes-presentant-une-elevation-de
2016
false
United Kingdom
France
French
meta-analysis
treatment outcome
hypertension
anti-obesity agents
overweight
appetite depressants
lactones
sibutramine
piperidines
pyrazoles
cyclobutanes
french abstract
Rimonabant
Orlistat
---
https://www.ema.europa.eu/medicines/human/EPAR/alli-previously-orlistat-gsk
2012
false
United Kingdom
French
syndication feed
anti-obesity agents
lactones
anti-obesity agents
enzyme inhibitors
lactones
capsules
administration, oral
treatment outcome
lipase
obesity
orlistat
drug evaluation
Orlistat
Orlistat
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68047259
2012
France
summary of product characteristics
package leaflet
capsules
Orlistat
---
https://www.ema.europa.eu/medicines/human/EPAR/Xenical
2012
United Kingdom
English
French
syndication feed
lactones
anti-obesity agents
obesity
treatment outcome
drug evaluation
lipase
enzyme inhibitors
orlistat
anti-obesity agents
enzyme inhibitors
drug evaluation
summary of product characteristics
package leaflet
Orlistat
Orlistat
---
http://www.cbip.be/pdf/tft/TF_OBES.pdf
2010
Belgium
French
pediatric obesity
obesity
obesity
obesity
treatment outcome
weight loss
diet, reducing
exercise
obesity
obesity
appetite depressants
anti-obesity agents
appetite depressants
anti-obesity agents
bariatric surgery
Outcome Assessment, Health Care
child
adolescent
sibutramine
lactones
cyclobutanes
piperidines
pyrazoles
practice guideline
table
Rimonabant
Orlistat
---
http://www.cbip.be/nieuws/index.cfm?welk=326
2009
Belgium
journal article
No-Observed-Adverse-Effect level
Orlistat
---
http://www.lecrat.eu/?s=Orlistat
2008
France
French
pregnancy
lipase
anti-obesity agents
enzyme inhibitors
lactones
orlistat
drug information
Orlistat
---
http://www.has-sante.fr/portail/display.jsp?id=c_443495
http://www.has-sante.fr/portail/jcms/c_443494/xenical-ct-2826
http://www.has-sante.fr/portail/jcms/c_604808/xenical-ct-2826-english
2006
France
French
English
anti-obesity agents
enzyme inhibitors
lipase
administration, oral
insurance, health, reimbursement
adult
treatment outcome
lactones
orlistat
lactones
evaluation of the transparency committee
Orlistat
---